Who’s Running The US FDA? Interim Team May Not Have Assumed Control

The White House is expected to name Sara Brenner, chief medical officer for in vitro diagnostics at CDRH and a veteran of the first Trump administration, as acting commissioner, but the lack of a formal announcement is creating uncertainty. New executive orders on telework and the senior executive service also could impact agency staff.